Questions discussed in this category
Considering poor outcomes/lack of long-term benefit for NGT/PEG placement in this population.
E.g., amyloid PET, CSF amyloid, blood-based amyloid.
What factors might drive decisions for different SSRIs and/or doses?
E.g., primary progressive aphasia
As studied in Tang H, Donahoo WT, DeKosky ST, et al. GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related De...
From a geriatrics harm-reduction standpoint, can we recommend any particulars regarding dosing or selection of therapies when used as a last resort?
269712529726887263352646525316253182629323149256182532025319252962532114876
Papers discussed in this category
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2018-02
JAMA internal medicine, 2025 May 01
Alzheimer's & dementia (New York, N. Y.), 2022 Jan 31
The Medical journal of Australia, 2019 Feb 16
The American journal of psychiatry, 2016-05-01
The American journal of psychiatry, 2016-05-01
JAMA, 2014 Feb 19
Frontiers in aging neuroscience, 2023 Mar 03
Journal of Alzheimer's disease : JAD, 2020
Journal of the American Geriatrics Society, 2025 Apr 28
Journal of the American Geriatrics Society, 2016 Mar 23
The Cochrane database of systematic reviews, 2018 Jun 18
JAMA, 2011-09-28
The Cochrane database of systematic reviews, 2014-03-21
Translational psychiatry, 2022 Apr 01
Journal of sleep research, 2020 Dec 02
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2016 Jan 27
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022 Dec 01
CNS drugs, 2024 Aug 09
Journal of oncology practice, 2017-10
Journal of the American Geriatrics Society, 2019 Aug 20
Handbook of clinical neurology, 2022
Journal of the American Geriatrics Society, 2014 Jul 17
JAMA, 2025 Aug 12